Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
Apr. 30, 2024
Oct. 31, 2023
CURRENT ASSETS    
Cash and Cash Equivalents $ 23,709,676 $ 24,448,841
Accounts Receivable 4,402,355 2,643,461
Inventory 12,645,976 11,685,525
Unbilled Receivables 1,580,546 894,251
Prepaid Expenses 786,490 181,383
Other Current Assets 706,491 1,034,626
Total Current Assets 43,831,534 40,888,087
FIXED ASSETS    
Property and Equipment, net 6,261,124 6,873,320
OTHER ASSETS    
Goodwill 3,382,108 3,382,108
Intangible Assets, net 522,390 486,615
Deferred Tax Asset 211,386
Total Other Assets 3,904,498 4,080,109
Total Assets 53,997,156 51,841,516
CURRENT LIABILITIES    
Accounts Payable 1,212,484 1,308,201
Accrued Expenses and Other Current Liabilities 884,182 995,630
Deferred Revenue 721,167 975,537
Total Current Liabilities 2,817,833 3,279,368
LONG TERM LIABILITIES    
Deferred Tax Liability 10,589
Deferred Revenue, less current portion 102,364 133,382
Total Liabilities 2,930,786 3,412,750
STOCKHOLDERS’ EQUITY    
Common Stock, $.001 par value; 150,000,000 shares authorized, 11,172,683 issued and outstanding as of April 30, 2024 and 11,117,695 shares issued and outstanding as of October 31, 2023 11,173 11,118
Treasury Stock (61,933) (46,300)
Additional Paid-in Capital 62,975,143 62,958,984
Accumulated Other Comprehensive Loss (2,850,652) (3,442,549)
Accumulated Deficit (9,007,361) (11,052,487)
Total Stockholders’ Equity 51,066,370 48,428,766
Total Liabilities and Stockholders’ Equity $ 53,997,156 $ 51,841,516